Ebola declared a global health emergency as cases jump from DRC to Uganda. The rare Bundibugyo strain has no vaccine, raising significant international health concerns amid ongoing violence and distrust in affected regions.
WHO Declares Public Health Emergency
The World Health Organization (WHO) has declared the ongoing Ebola outbreak a public health emergency of international concern as cases spread from the Democratic Republic of Congo (DRC) to Uganda. The outbreak, caused by the rare Bundibugyo strain of Ebola, has now surpassed 900 suspected cases and 220 deaths in the DRC, with seven confirmed cases in Uganda. The WHO upgraded the public health risk from 'high' to 'very high' for the DRC, though the global risk remains low.
Immediate Action & Core Facts
The WHO's declaration follows the confirmation of Ebola cases in Uganda, including two health workers and a driver exposed to a Congolese patient who died in Kampala. The outbreak, centered in the DRC's Ituri province, has been hampered by attacks on treatment centers and distrust of authorities in a region plagued by armed violence. Scientists at Oxford University are racing to develop a vaccine for the Bundibugyo strain, but clinical trials are not expected to begin for two to three months.
Deeper Dive & Context
Outbreak Details
The Bundibugyo strain, first recorded in 2007, has no approved vaccine or treatment. Previous Ebola outbreaks have killed more than half of those infected, often due to internal bleeding and organ failure. The current outbreak was declared on May 15, but cases may have emerged earlier.
Response and Challenges
Health workers are 'playing catch-up' due to delays in detecting cases, according to WHO Director-General Tedros Adhanom Ghebreyesus. Flights to and from Bunia, a city in eastern DRC, have been grounded, but experts fear the virus may have already spread to neighboring countries like South Sudan. The response has been further complicated by local anger and attacks on treatment centers.
Vaccine Development
Oxford University scientists are working on a Bundibugyo vaccine, but it will take months before human trials can begin. The existing vaccine protects against the Zaire strain, the most common form of Ebola, but not the Bundibugyo variant. The experimental jab, if successful, could protect patients from severe illness and limit the virus's spread.
Global Implications
The WHO has emphasized that the risk of global spread remains low, but the outbreak poses a 'very high' risk for the DRC. The organization's declaration aims to mobilize international resources and coordination to contain the outbreak.